Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Qasim, Waseem  [Clear All Filters]
Journal Article
Chiesa R, Georgiadis C, Syed F, Zhan H, Etuk A, Gkazi SAthina, Preece R, Ottaviano G, Braybrook T, Chu J, et al. Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia. N Engl J Med. 2023.
Naso G, Gkazi SAthina, Georgiadis C, Jayarajan V, Jacków J, Fleck R, Allison L, Ogunbiyi OKayode, McGrath JAlexander, Ilic D, et al. Cytosine Deaminase Base Editing to Restore in Dystrophic Epidermolysis Bullosa Human: Murine Skin Model. JID Innov. 2023;3(3):100191.
Jayarajan V, Kounatidou E, Qasim W, Di W-L. Ex-vivo gene modification therapy for genetic skin diseases - recent advances in gene modification technologies and delivery. Exp Dermatol. 2021.
Hiwarkar P, Gajdosova E, Qasim W, Worth A, Breuer J, Chiesa R, Ridout D, Edelsten C, Moore A, Amrolia P, et al. Frequent occurrence of Cytomegalovirus retinitis during immune-reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients. Clin Infect Dis. 2014.
Elfeky R, Lazareva A, Qasim W, Veys P. Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources. Expert Rev Clin Immunol. 2019:1-17.
Ip WWy, Qasim W. Management of Adenovirus in Children after Allogeneic Hematopoietic Stem Cell Transplantation. Adv Hematol. 2013;2013:176418.
Horlock C, Skulte A, Mitra A, Stansfield A, Bhandari S, Ip W, Qasim W, Lowdell MW, Patel S, Friedetzky A, et al. Manufacture of GMP-compliant functional adenovirus-specific T-cell therapy for treatment of post-transplant infectious complications. Cytotherapy. 2016.
Elfeky R, Shah RM, Unni MNm, Ottaviano G, Rao K, Chiesa R, Amrolia P, Worth A, Flood T, Abinun M, et al. New graft manipulation strategies improved outcome of mismatched stem cell transplantation in children with primary immunodeficiencies. J Allergy Clin Immunol. 2019.
Elfeky R, Lucchini G, Lum S-H, Ottaviano G, Builes N, Nademi Z, Battersby A, Flood T, Owens S, Cant AJ, et al. New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT. Blood Adv. 2020;4(11):2418-2429.
Golwala ZM, Bhat NGireesh, Xu-Bayford J, Stankova T, Adams S, Morris EC, Qasim W, Booth C, Worth A, Kusters MA, et al. Non-osteopenic Bone Pathology After Allo-hematopoietic Stem Cell Transplantation in Patients with Inborn Errors of Immunity. J Clin Immunol. 2023.
Lum SHan, Elfeky R, Achini FR, Margarit-Soler A, Cinicola B, Perez-Heras I, Nademi Z, Flood T, Cheetham T, Worth A, et al. Outcome of Non-hematological Autoimmunity After Hematopoietic Cell Transplantation in Children with Primary Immunodeficiency. J Clin Immunol. 2020.
Ottaviano G, Georgiadis C, Gkazi SAthina, Syed F, Zhan H, Etuk A, Preece R, Chu J, Kubat A, Adams S, et al. Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia. Sci Transl Med. 2022;14(668):eabq3010.
Zhan H, Gilmour K, Chan L, Farzaneh F, McNicol AMarie, Xu J-H, Adams S, Fehse B, Veys P, Thrasher A, et al. Production and First-in-Man Use of T Cells Engineered to Express a HSVTK-CD34 Sort-Suicide Gene. PLoS One. 2013;8(10):e77106.